JumpCode Genomics, Inc. logo

JumpCode Genomics, Inc.

JumpCode Genomics develops NGS solutions for the oncology, infectious disease, basic research, and consumer genomics fields.

3

Funding Rounds

$45.5m

Money raised

Overview

JumpCode Genomics develops NGS solutions for the oncology, infectious disease, basic research, and consumer genomics fields.

Funding series

Funding Series Analysis

The company JumpCode Genomics, Inc. has raised a total of $21m in funding over 3 rounds.

Key Insights:

  • JumpCode Genomics, Inc. Series B round, February 2021: $21m
  • JumpCode Genomics, Inc. funding round, September 2018: $3.51m
  • JumpCode Genomics, Inc. Series B round January 2021: $21m
JumpCode Genomics, Inc. logo
JumpCode Genomics, Inc. Series B round, February 2021 $21m
JumpCode Genomics, Inc. logo
JumpCode Genomics, Inc. funding round, September 2018 $3.51m
JumpCode Genomics, Inc. logo
JumpCode Genomics, Inc. Series B round January 2021 $21m

Industries

JumpCode Genomics, Inc. is active in the following industries: